The DOI matches its Crossref record; 325 of the 325 references it cites were found in a registry or an index.
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Open accessAbstract
Cannabis is the most commonly used illicit drug worldwide, with ~5 million daily users worldwide. Emerging evidence supports a number of associations between cannabis and psychosis/psychotic disorders, including schizophrenia. These associations-based on case-studies, surveys, epidemiological studies, and experimental studies indicate that cannabinoids can produce acute, transient effects; acute, persistent effects; and delayed, persistent effects that recapitulate the psychopathology and psychophysiology seen in schizophrenia. Acute exposure to both cannabis and synthetic cannabinoids (Spice/K2) can produce a full range of transient psychotomimetic symptoms, cognitive deficits, and psychophysiological abnormalities that bear a striking resemblance to symptoms of schizophrenia. In individuals with an established psychotic disorder, cannabinoids can exacerbate symptoms, trigger relapse, and have negative consequences on the course of the illness. Several factors appear to moderate these associations, including family history, genetic factors, history of childhood abuse, and the age at onset of cannabis use. Exposure to cannabinoids in adolescence confers a higher risk for psychosis outcomes in later life and the risk is dose-related. Individuals with polymorphisms of COMT and AKT1 genes may be at increased risk for psychotic disorders in association with cannabinoids, as are individuals with a family history of psychotic disorders or a history of childhood trauma. The relationship between cannabis and schizophrenia fulfills many but not all of the standard criteria for causality, including temporality, biological gradient, biological plausibility, experimental evidence, consistency, and coherence. At the present time, the evidence indicates that cannabis may be a component cause in the emergence of psychosis, and this warrants serious consideration from the point of view of public health policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Rice, D., & Barone, S. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3511 · Cited by 2,944
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00634.x · Cited by 1,534
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523 · cited 3×
“Therefore, although continued cannabis use results in a decline in their individual cognitive performance (242, 248, 249), when compared to non-users they appear to have relatively better cognitive performance.”
BackgroundCaspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Adolescent cortical development: A critical period of vulnerability for addiction
Crews, F., He, J., & Hodge, C. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.001 · Cited by 1,091
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Self-citationThe neurodevelopmental model of schizophrenia: update 2005
Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. C. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001642 · Cited by 993
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Causal association between cannabis and psychosis: examination of the evidence
Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 913
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
Regional and cellular fractionation of working memory
Goldman-Rakic, P. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13473 · Cited by 812
Tobacco smoking and cancer: a brief review of recent epidemiological evidence
Sasco, A. J., Secretan, M. B., & Straif, K. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.998 · Cited by 804
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 772
Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765
Neuropsychology and neuropharmacology of P3a and P3b
Polich, J., & Criado, J. R. (2006) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.12.012 · Cited by 741
Information Processing and Attention Dysfunctions in Schizophrenia
Braff, D. L. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.233 · Cited by 738
Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732
Catechol-o-Methyltransferase, Cognition, and Psychosis: Val158Met and Beyond
Tunbridge, E. M., Harrison, P. J., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.024 · Cited by 685
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?
Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1558 · Cited by 660
Cannabis Abuse and the Course of Recent-Onset Schizophrenic Disorders
Linszen, D. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950040017002 · Cited by 656
Neuropsychological Performance in Long-term Cannabis Users
Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.909 · Cited by 655
Macleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., Oppenkowski, T., Stokes-Lampard, H., & Smith, G. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16200-4 · Cited by 639
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610
PKB/AKT: functional insights from genetic models
Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 609
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Meta-analysis of the P300 and P50 waveforms in schizophrenia
BRAMON, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.004 · Cited by 569
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 567
Cannabis Use and Earlier Onset of Psychosis: A Systematic Meta-analysis
Large, M., Sharma, S., Compton, M. T., Slade, T., & Nielssen, O. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.5 · Cited by 563
Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms
Andreasen, N. C., Nopoulos, P., O’Leary, D. S., Miller, D. D., Wassink, T., & Flaum, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00152-3 · Cited by 560
Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity
Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., et al. (2007) · Science · doi:10.1126/science.1137406 · Cited by 551
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00334-4 · Cited by 543
Neural synchrony and the development of cortical networks
Uhlhaas, P. J., Roux, F., Rodriguez, E., Rotarska-Jagiela, A., & Singer, W. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2009.12.002 · Cited by 532
The acute effects of cannabinoids on memory in humans: a review
Ranganathan, M., & D’Souza, D. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0508-y · Cited by 525
Self-citationSeparate Time Behaviors of the Temporal and Frontal Mismatch Negativity Sources
Rinne, T., Alho, K., Ilmoniemi, R. J., Virtanen, J., & Näätänen, R. (2000) · NeuroImage · doi:10.1006/nimg.2000.0591 · Cited by 514
People living with psychotic illness in 2010: the second Australian national survey of psychosis
Morgan, V. A., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J. J., Carr, V., Bush, R., Castle, D., Cohen, M., Harvey, C., et al. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449877 · Cited by 504
Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A. S., Ross, S. A., Khan, I. A., & ElSohly, M. A. (2010) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2010.01441.x · Cited by 475
Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 462
Meta‐analysis of P300 and schizophrenia: Patients, paradigms, and practical implications
Jeon, Y., & Polich, J. (2003) · Psychophysiology · doi:10.1111/1469-8986.00070 · Cited by 455
The Environment and Schizophrenia: The Role of Cannabis Use
Henquet, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi027 · Cited by 454
The emerging functions of endocannabinoid signaling during CNS development
Harkany, T., Guzmán, M., Galve-Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.004 · Cited by 432
Cannabis as a risk factor for psychosis: Systematic review
Semple, D. M., McIntosh, A. M., & Lawrie, S. M. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105049040 · Cited by 420
A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1
Mechoulam, R., & Gaoni, Y. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01092a065 · Cited by 400
Chemical neuromodulation of frontal-executive functions in humans and other animals
Robbins, T. W. (2000) · Experimental Brain Research · doi:10.1007/s002210000407 · Cited by 396
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Bossong, M. G., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R. C., Windhorst, A. D., van Gerven, J. M. A., Ramsey, N. F., Lammertsma, A. A., & Kahn, R. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 392
Being stoned: a review of self‐reported cannabis effects
GREEN, B., KAVANAGH, D., & YOUNG, R. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390
Endocannabinoid signaling system and brain reward: emphasis on dopamine
GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387
The Chronic Effects of Cannabis on Memory in Humans: A Review
Solowij, N., & Battisti, R. (2008) · Current Drug Abuse Reviewse · doi:10.2174/1874473710801010081 · Cited by 380
Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
French, E. D., Dillon, K., & Wu, X. (1997) · NeuroReport · doi:10.1097/00001756-199702100-00014 · Cited by 374
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
Gessa, G., Melis, M., Muntoni, A., & Diana, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01442-8 · Cited by 370
Effects of THC on Behavioral Measures of Impulsivity in Humans
McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300176 · Cited by 368
Brewer, W. J., Francey, S. M., Wood, S. J., Jackson, H. J., Pantelis, C., Phillips, L. J., Yung, A. R., Anderson, V. A., & McGorry, P. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.71 · Cited by 366
P50 sensory gating ratios in schizophrenics and controls: A review and data analysis
Patterson, J. V., Hetrick, W. P., Boutros, N. N., Jin, Y., Sandman, C., Stern, H., Potkin, S., & Bunney, W. E. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.02.009 · Cited by 352
The Residual Cognitive Effects of Heavy Marijuana Use in College Students
Pope, H. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530310027028 · Cited by 350
The endogenous cannabinoid system and brain development
Fernández-Ruiz, J., Berrendero, F., Hernández, M. L., & Ramos, J. A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01491-5 · Cited by 347
Spice drugs as a new trend: Mode of action, identification and legislation
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.06.002 · Cited by 341
Early adolescent cannabis exposure and positive and negative dimensions of psychosis
Stefanis, N. C., Delespaul, P., Henquet, C., Bakoula, C., Stefanis, C. N., & Van Os, J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00806.x · Cited by 340
Substance abuse and the onset of schizophrenia
Hambrecht, M., & Häfner, H. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(95)00609-5 · Cited by 339
LUNDQVIST, T. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.017 · Cited by 331
Degenhardt, L., Hall, W., & Lynskey, M. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.961116037.x · Cited by 330
Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning
Mulder, J., Aguado, T., Keimpema, E., Barabás, K., Ballester Rosado, C. J., Nguyen, L., Monory, K., Marsicano, G., Di Marzo, V., Hurd, Y. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803545105 · Cited by 327
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure
Schneider, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00110.x · Cited by 316
VERDEJO-GARCÍA, A., BECHARA, A., RECKNOR, E. C., & PÉREZ-GARCÍA, M. (2006) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617706060486 · Cited by 315
Dresen, S., Ferreirós, N., Pütz, M., Westphal, F., Zimmermann, R., & Auwärter, V. (2010) · Journal of Mass Spectrometry · doi:10.1002/jms.1811 · Cited by 309
Rates of Psychiatric Comorbidity Among U.S. Residents with Lifetime Cannabis Dependence
Agosti, V., Nunes, E., & Levin, F. (2002) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-120015873 · Cited by 307
Kuepper, R., van Os, J., Lieb, R., Wittchen, H.-U., Hofler, M., & Henquet, C. (2011) · BMJ · doi:10.1136/bmj.d738 · Cited by 304 · cited 2×
“However, this has not been supported by recent literature (28, 250, 251, 267).”
MethodResultCannabis use before age 15 and subsequent executive functioning
Fontes, M. A., Bolla, K. I., Cunha, P. J., Almeida, P. P., Jungerman, F., Laranjeira, R. R., Bressan, R. A., & Lacerda, A. L. T. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.077479 · Cited by 300
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every-Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 299
Henquet, C., Rosa, A., Krabbendam, L., Papiol, S., Faňanás, L., Drukker, M., Ramaekers, J. G., & van Os, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301197 · Cited by 299
Morrison, P. D., Zois, V., McKeown, D. A., Lee, T. D., Holt, D. W., Powell, J. F., Kapur, S., & Murray, R. M. (2009) · Psychological Medicine · doi:10.1017/s0033291709005522 · Cited by 298
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
Self-citationCannabis and psychosis/schizophrenia: human studies
D’Souza, D. C., Sewell, R. A., & Ranganathan, M. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0024-2 · Cited by 295
Self-citationMartin-Santos, R., A. Crippa, J., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., Allen, P., Seal, M., Langohr, K., Farre, M., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884780 · Cited by 295
Some Features of the Auditory Evoked Response in Schizophrenics
Roth, W. T. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750280034007 · Cited by 293
O'Shea, M., Singh, M. E., Mcgregor, I. S., & Mallet, P. E. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800407 · Cited by 293
Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291
Hermann, H., Marsicano, G., & Lutz, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00509-7 · Cited by 290
Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301475 · Cited by 290
Papaleo, F., Crawley, J. N., Song, J., Lipska, B. K., Pickel, J., Weinberger, D. R., & Chen, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2077-08.2008 · Cited by 288
A survey study to characterize use of Spice products (synthetic cannabinoids)
Vandrey, R., Dunn, K. E., Fry, J. A., & Girling, E. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.011 · Cited by 283
Lee, P. N., Forey, B. A., & Coombs, K. J. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-385 · Cited by 280
McGrath, J., Welham, J., Scott, J., Varghese, D., Degenhardt, L., Hayatbakhsh, M. R., Alati, R., Williams, G. M., Bor, W., & Najman, J. M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.6 · Cited by 276
Defective Adult Neurogenesis in CB1 Cannabinoid Receptor Knockout Mice
Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J., & Greenberg, D. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.2.204 · Cited by 273
Effects of Acute Smoked Marijuana on Complex Cognitive Performance
Hart, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00273-1 · Cited by 271
Testing hypotheses about the relationship between cannabis use and psychosis
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270
The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells
Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., & Galve-Roperh, I. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3101-05.2006 · Cited by 269
Tests of causal linkages between cannabis use and psychotic symptoms
Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01001.x · Cited by 268
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2
Mir, A., Obafemi, A., Young, A., & Kane, C. (2011) · Pediatrics · doi:10.1542/peds.2010-3823 · Cited by 266
Eggan, S. M., & Lewis, D. A. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj136 · Cited by 264
D'Souza, D. C., Ranganathan, M., Braley, G., Gueorguieva, R., Zimolo, Z., Cooper, T., Perry, E., & Krystal, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301643 · Cited by 262
Self-citationArendt, M., Rosenberg, R., Foldager, L., Perto, G., & Munk-Jørgensen, P. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.6.510 · Cited by 257
Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq079 · Cited by 255
Neurocognitive consequences of marihuana—a comparison with pre-drug performance
Fried, P. A., Watkinson, B., & Gray, R. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.11.003 · Cited by 253
Perez, V. B., Woods, S. W., Roach, B. J., Ford, J. M., McGlashan, T. H., Srihari, V. H., & Mathalon, D. H. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.038 · Cited by 246
Wiles, N. J., Zammit, S., Bebbington, P., Singleton, N., Meltzer, H., & Lewis, G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012179 · Cited by 245
On the Plausibility of “The Neurodevelopmental Hypothesis” of Schizophrenia
Weinberger, D. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00199-n · Cited by 245
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., & Goda, Y. (2010) · Forensic Science International · doi:10.1016/j.forsciint.2010.01.004 · Cited by 245
French, E. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00278-4 · Cited by 236
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users
Di Forti, M., Iyegbe, C., Sallis, H., Kolliakou, A., Falcone, M. A., Paparelli, A., Sirianni, M., La Cascia, C., Stilo, S. A., Marques, T. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.020 · Cited by 234
Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., & Devoto, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03055-x · Cited by 227
MACHADO ROCHA, F. C., STÉFANO, S. C., DE CÁSSIA HAIEK, R., ROSA OLIVEIRA, L. M. Q., & DA SILVEIRA, D. X. (2008) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.00917.x · Cited by 223
Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study
Bramon, E., McDonald, C., Croft, R. J., Landau, S., Filbey, F., Gruzelier, J. H., Sham, P. C., Frangou, S., & Murray, R. M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.05.022 · Cited by 222
Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222
Differential impairments of selective attention due to frequency and duration of cannabis use
Solowij, N., Michie, P. T., & Fox, A. M. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00178-6 · Cited by 217
Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain
Ozaita, A., Puighermanal, E., & Maldonado, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04642.x · Cited by 216
Compton, D. R., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 215
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
“Spice” Girls: Synthetic Cannabinoid Intoxication
Schneir, A. B., Cullen, J., & Ly, B. T. (2011) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2010.10.014 · Cited by 215
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212
Severe Toxicity Following Synthetic Cannabinoid Ingestion
Lapoint, J., James, L. P., Moran, C. L., Nelson, L. S., Hoffman, R. S., & Moran, J. H. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.609822 · Cited by 212
Niemi-Pynttäri, J. A., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K., & Pirkola, S. P. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07822 · Cited by 211
Verdejo-Garcı́a, A. J., López-Torrecillas, F., Aguilar de Arcos, F., & Pérez-Garcı́a, M. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.04.015 · Cited by 210
Harley, M., Kelleher, I., Clarke, M., Lynch, F., Arseneault, L., Connor, D., Fitzpatrick, C., & Cannon, M. (2010) · Psychological Medicine · doi:10.1017/s0033291709991966 · Cited by 206
Long‐term cannabis use: characteristics of users in an Australian rural area
Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9368375.x · Cited by 206
Bhattacharyya, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.161 · Cited by 203
Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?
Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 203
Is schizophrenia disappearing?
Der, G., Gupta, S., & Murray, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)90745-q · Cited by 202
Salt and hypertension: is salt dietary reduction worth the effort?
Frisoli, T. M., Schmieder, R. E., Grodzicki, T., & Messerli, F. H. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.10.023 · Cited by 200
The residual neuropsychological effects of cannabis: the current status of research
Pope, H. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01097-i · Cited by 196
Green, A. I., Tohen, M. F., Hamer, R. M., Strakowski, S. M., Lieberman, J. A., Glick, I., & Scott Clark, W. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.08.001 · Cited by 195
DEGENHARDT, L., & HALL, W. (2001) · Psychological Medicine · doi:10.1017/s0033291701003865 · Cited by 193
Psychotic Reactions Following Cannabis Use in East Indians
Chopra, G. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760070014002 · Cited by 193
Schneider, M., Schömig, E., & Leweke, F. M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00117.x · Cited by 189
Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189
Long-term effects of frequent cannabis use on working memory and attention: an fMRI study
Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., & Ramsey, N. F. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0298-7 · Cited by 186
van Winkel, R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.152 · Cited by 183
Müller, H., Sperling, W., Köhrmann, M., Huttner, H. B., Kornhuber, J., & Maler, J.-M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.001 · Cited by 183
Luck, S. J., Mathalon, D. H., O'Donnell, B. F., Hämäläinen, M. S., Spencer, K. M., Javitt, D. C., & Uhlhaas, P. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.021 · Cited by 182
CANNABIS-ASSOCIATED PSYCHOSIS WITH HYPOMANIC FEATURES
ROTTANBURG, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91270-3 · Cited by 178
Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes
Bersani, G., Orlandi, V., Kotzalidis, G. D., & Pancheri, P. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-002-0366-5 · Cited by 176
Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences
TIEN, A. Y., & ANTHONY, J. C. (1990) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199008000-00001 · Cited by 175
Zammit, S., Spurlock, G., Williams, H., Norton, N., Williams, N., O'Donovan, M. C., & Owen, M. J. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036129 · Cited by 174
Hinkley, S. W. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780270119020 · Cited by 173
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
Diana, M., Melis, M., & Gessa, G. L. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00292.x · Cited by 173
Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product
Uchiyama, N., Kikura-Hanajiri, R., Kawahara, N., Haishima, Y., & Goda, Y. (2009) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.57.439 · Cited by 172
Hajós, M., Hoffmann, W. E., & Kocsis, B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.005 · Cited by 170
Boucher, A. A., Arnold, J. C., Duffy, L., Schofield, P. R., Micheau, J., & Karl, T. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0721-3 · Cited by 168
Thiselton, D. L., Vladimirov, V. I., Kuo, P., McClay, J. L., Wormley, B., Fanous, A. H., O’Neill, F. A., Walsh, D., van den Oord, E. J. C. G., Kendler, K. S., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.005 · Cited by 168
From child maltreatment to adolescent cannabis abuse and dependence: A developmental cascade model
Rogosch, F. A., Oshri, A., & Cicchetti, D. (2010) · Development and Psychopathology · doi:10.1017/s0954579410000520 · Cited by 167
Δ9-Tetrahydroeannabinol enhances presynaptic dopamine efflux In medial prefrontal cortex
Jianping, C., Paredes, W. M., Lowinson, J. H., & Gardner, E. L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)94136-l · Cited by 166
de Wilde, O. M., Bour, L. J., Dingemans, P. M., Koelman, J. H. T. M., & Linszen, D. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.028 · Cited by 166
Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis
McGuire, P. K., Jones, P., Harvey, I., Williams, M., McGuffin, P., & Murray, R. M. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00053-b · Cited by 165
The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation.
Watson, S., Chambers, D., Hobbs, C., Doherty, P., & Graham, A. (2008) · Molecular and cellular neurosciences · doi:10.1016/j.mcn.2008.02.001 · Cited by 164
Psychiatric Effects of Hashish
Tennant, F. S. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750250117016 · Cited by 164
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
Ilan, A. B., Gevins, A., Coleman, M., ElSohly, M. A., & de Wit, H. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00023 · Cited by 163
Houston, J. E., Murphy, J., Adamson, G., Stringer, M., & Shevlin, M. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm127 · Cited by 162
Ganja in Jamaica: A medical anthropological study of chronic marihuana use
Rubin, V. C., & Comitas, L. (1975) · De Gruyter eBooks · doi:10.1515/9783110812077 · Cited by 160
Manrique-Garcia, E., Zammit, S., Dalman, C., Hemmingsson, T., Andréasson, S., & Allebeck, P. (2011) · Psychological Medicine · doi:10.1017/s0033291711002078 · Cited by 160
Jentsch, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00018-3 · Cited by 158
SANCHEZ, M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00036-6 · Cited by 158
Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man
Leweke, F. M., Schneider, U., Radwan, M., Schmidt, E., & Emrich, H. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00201-x · Cited by 157
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series
Hurst, D., Loeffler, G. H., & McLay, R. N. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010176 · Cited by 156
Differential effects of delta9-THC on learning in adolescent and adult rats
Cha, Y. M., White, A. M., Kuhn, C. M., Wilson, W. A., & Swartzwelder, H. S. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.03.006 · Cited by 155
Cognitive Measures in Long‐Term Cannabis Users
Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. A. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb06002.x · Cited by 153
Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain
Jain, A. K., Ryan, J. R., McMahon, F. G., & Smith, G. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02610.x · Cited by 150
A network of dopaminergic gene variations implicated as risk factors for schizophrenia
Talkowski, M. E., Kirov, G., Bamne, M. N., Georgieva, L., Torres, G. E., Mansour, H., Chowdari, K. V., Milanova, V. K., Wood, J. A., McClain, L. L., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm347 · Cited by 149
González-Pinto, A. M., Alberich, S., Barbeito, S., Gutiérrez, M., Vega, P., Ibáñez, B., Haidar, K., Vieta, E., & Arango, C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp126 · Cited by 145
Can recreational doses of THC produce significant dopamine release in the human striatum?
Stokes, P. R. A., Mehta, M. A., Curran, H. V., Breen, G. D., & Grasby, P. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.06.029 · Cited by 141
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
Rabin, R. A., Zakzanis, K. K., & George, T. P. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.017 · Cited by 140
College students and use of K2: an emerging drug of abuse in young persons
Hu, X., Primack, B. A., Barnett, T. E., et al. (2011) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-6-16 · Cited by 140
Heishman, S. J., Huestis, M. A., Henningfield, J. E., & Cone, E. J. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90028-g · Cited by 138
Endocannabinoids in cognition and dependence
Lichtman, A. H., Varvel, S. A., & Martin, B. R. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0351 · Cited by 138
Potvin, S., Joyal, C. C., Pelletier, J., & Stip, É. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.022 · Cited by 138
Cannabis, COMT and psychotic experiences
Zammit, S., Owen, M. J., Evans, J., Heron, J., & Lewis, G. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.091421 · Cited by 136
D’Souza, D. C., Braley, G., Blaise, R., Vendetti, M. S., Oliver, S., Pittman, B. P., Ranganathan, M., Bhakta, S. G., Zimolo, Z., Cooper, T. B., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1042-2 · Cited by 134
Self-citationDo cognitive impairments recover following cessation of cannabis use ?
Solowij, N. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00197-e · Cited by 133
Turetsky, B. I., Colbath, E. A., & Gur, R. E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00258-8 · Cited by 133
Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County
Allebeck, P., Adamsson, C., Engström, A., & Rydberg, U. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03408.x · Cited by 132
Psychosis reactivity to cannabis use in daily life: an experience sampling study
Henquet, C., van Os, J., Kuepper, R., Delespaul, P., Smits, M., Campo, J. Á., & Myin‐Germeys, I. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.072249 · Cited by 129
The Endocannabinoid System and Neurogenesis in Health and Disease
Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296407 · Cited by 129
The residual cognitive effects of heavy marijuana use in college students
Jnr, H. G. P., & Yurgelun-Todd, D. A. (1996) · Journal of Clinical Forensic Medicine · doi:10.1016/s1353-1131(96)90030-9 · Cited by 127
(2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.132 · Cited by 126
Acute and Chronic Toxicity of Marijuana
Smith, D. E. (1968) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1968.10524399 · Cited by 125
Effects of long-term cannabis use on selective attention: An event-related potential study
Solowij, N., Michie, P. T., & Fox, A. M. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90382-c · Cited by 125
Schulze, G. E., McMillan, D. E., Bailey, J. R., Scallet, A. C., Ali, S. F., Slikker, W., & Paule, M. G. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22284-4 · Cited by 124
Premorbid cognitive deficits in young relatives of schizophrenia patients
Keshavan, M. S., Kulkarni, S., Bhojraj, T. S., Francis, A., Diwadkar, V. A., Montrose, D. M., Seidman, L. J., & Sweeney, J. A. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.062.2009 · Cited by 124
Effects of Marihuana on Adolescents and Young Adults
Kolansky, H., & Moore, W. T. (1971) · JAMA · doi:10.1001/jama.1971.03180290062009 · Cited by 124
The Incidence of Schizotypy among Cannabis and Alcohol Users
Nunn, J. A., Rizza, F., & PETERS, E. R. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200111000-00002 · Cited by 124
Plant cannabinoids: a neglected pharmacological treasure trove
Mechoulam, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706415 · Cited by 120
Cannabinoid self-administration increases dopamine release in the nucleus accumbens
Fadda, P., Scherma, M., Spano, M. S., Salis, P., Melis, V., Fattore, L., & Fratta, W. (2006) · Neuroreport · doi:10.1097/01.wnr.0000236853.40221.8e · Cited by 118
Ho, B., Wassink, T. H., Ziebell, S., & Andreasen, N. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.021 · Cited by 118
Henquet, C., Rosa, A., Delespaul, P., Papiol, S., Fañanás, L., van Os, J., & Myin‐Germeys, I. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01265.x · Cited by 117
Cannabis Psychosis and Paranoid Schizophrenia
Thacore, V. R. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030081012 · Cited by 116
Bhattacharyya, S., Atakan, Z., Martín‐Santos, R., Crippa, J. A., Kambeitz, J. P., Prata, D. P., Williams, S., Brammer, M. J., Collier, D. A., & McGuire, P. K. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.187 · Cited by 115
Cited by
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2016) · Leukemia · doi:10.1038/leu.2015.247 · Cited by 867
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Metadata
- Authors
- Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2014-05-22
- Volume
- 5
- Pages
- 54-54
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2040750242
- Cited by
- 310
- References
- 325
- FWCI
- 24.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.